268 related articles for article (PubMed ID: 32077101)
1. Minimally invasive oesophagectomy with extended lymph node dissection and thoracic duct resection for early-stage oesophageal squamous cell carcinoma.
Matsuda S; Kawakubo H; Takeuchi H; Hayashi M; Mayanagi S; Takemura R; Irino T; Fukuda K; Nakamura R; Wada N; Kitagawa Y
Br J Surg; 2020 May; 107(6):705-711. PubMed ID: 32077101
[TBL] [Abstract][Full Text] [Related]
2. Minimally Invasive Esophagectomy with Thoracic Duct Resection Post Neoadjuvant Chemoradiotherapy for Carcinoma Esophagus-Impact on Lymph Node Yield and Hemodynamic Parameters.
Anand S; Kalayarasan R; Chandrasekar S; Gnanasekaran S; Pottakkat B
J Gastrointest Cancer; 2019 Jun; 50(2):230-235. PubMed ID: 29344808
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic thoracic duct ligation is associated with poor prognosis and regional lymph node relapse in esophageal squamous cell carcinoma.
Chen JY; Liu QW; Zhang SS; Li JB; Yang H; Wen J; Fu JH
J Surg Oncol; 2020 Aug; 122(2):336-343. PubMed ID: 32410255
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of transthoracic esophagectomy with thoracic duct resection: Number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct.
Matsuda S; Takeuchi H; Kawakubo H; Shimada A; Fukuda K; Nakamura R; Takahashi T; Wada N; Kameyama K; Kitagawa Y
Medicine (Baltimore); 2016 Jun; 95(24):e3839. PubMed ID: 27310961
[TBL] [Abstract][Full Text] [Related]
5. Three-field versus two-field lymphadenectomy in transthoracic oesophagectomy for oesophageal squamous cell carcinoma: short-term outcomes of a randomized clinical trial.
Li B; Hu H; Zhang Y; Zhang J; Miao L; Ma L; Luo X; Zhang Y; Ye T; Li H; Li Y; Shen L; Zhao K; Fan M; Zhu Z; Wang J; Xu J; Deng Y; Lu Q; Li H; Zhang Y; Pan Y; Liu S; Hu H; Shao L; Sun Y; Xiang J; Chen H
Br J Surg; 2020 May; 107(6):647-654. PubMed ID: 32108326
[TBL] [Abstract][Full Text] [Related]
6. Impact of examined lymph node count for oesophageal squamous cell carcinoma in patients who underwent left transthoracic oesophagectomy.
Zheng YZ; Li XQ; Wang JY; Yang H; Wen J; Zhai WY; Yuan LX; Fu SS; Liao HY; Fu JH
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1956-1962. PubMed ID: 32439262
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of minimally invasive Ivor Lewis and McKeown oesophagectomy in Chinese patients with stage IA-IIIB oesophageal squamous cell cancer: a multicentre, non-interventional and observational study.
Zhang T; Hou X; Li Y; Fu X; Liu L; Xu L; Liu Y
Interact Cardiovasc Thorac Surg; 2020 Jun; 30(6):812-819. PubMed ID: 32285107
[TBL] [Abstract][Full Text] [Related]
8. Thoracic Duct Resection During Esophagectomy Does Not Contribute to Improved Prognosis in Esophageal Squamous Cell Carcinoma: A Propensity Score Matched-Cohort Study.
Oshikiri T; Takiguchi G; Miura S; Goto H; Otsubo D; Hasegawa H; Yamamoto M; Kanaji S; Yamashita K; Matsuda T; Fujino Y; Tominaga M; Nakamura T; Suzuki S; Kakeji Y
Ann Surg Oncol; 2019 Nov; 26(12):4053-4061. PubMed ID: 31313045
[TBL] [Abstract][Full Text] [Related]
9. A Propensity Score-Matched Analysis of Thoracolaparoscopic vs Open McKeown's Esophagectomy.
Wang K; Zhong J; Liu Q; Lin P; Fu J
Ann Thorac Surg; 2022 Feb; 113(2):473-481. PubMed ID: 33621558
[TBL] [Abstract][Full Text] [Related]
10. Extended Right Thoracic Approach Compared With Limited Left Thoracic Approach for Patients With Middle and Lower Esophageal Squamous Cell Carcinoma: Three-year Survival of a Prospective, Randomized, Open-label Trial.
Li B; Hu H; Zhang Y; Zhang J; Miao L; Ma L; Luo X; Zhang Y; Ye T; Li H; Zhou J; Li Y; Shen L; Zhao K; Fan M; Zhu Z; Wang J; Xu J; Deng Y; Lu Q; Jia H; Cheng X; Li H; Zhang Y; Li C; Pan Y; Liu S; Hu H; Shao L; Sun Y; Xiang J; Chen H
Ann Surg; 2018 May; 267(5):826-832. PubMed ID: 28448385
[TBL] [Abstract][Full Text] [Related]
11. Does robot-assisted minimally invasive esophagectomy really have the advantage of lymphadenectomy over video-assisted minimally invasive esophagectomy in treating esophageal squamous cell carcinoma? A propensity score-matched analysis based on short-term outcomes.
Deng HY; Luo J; Li SX; Li G; Alai G; Wang Y; Liu LX; Lin YD
Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 30496378
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.
Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Nagasue N
Am J Surg; 2005 Jan; 189(1):98-109. PubMed ID: 15701501
[TBL] [Abstract][Full Text] [Related]
13. Survival risk prediction model for patients with pT
Qi Z; Hu Y; Qiu R; Li J; Li Y; He M; Wang Y
J Cardiothorac Surg; 2021 May; 16(1):121. PubMed ID: 33933129
[TBL] [Abstract][Full Text] [Related]
14. Exploration of lymph node recurrence patterns and delineation guidelines of radiation field in middle thoracic oesophageal carcinomas after radical surgery: a real-world study.
Du R; Fan S; Yang D; Wang X; Hou X; Zeng C; Guo D; Tian R; Jiang L; Dong X; Yu R; Yu H; Zhu S; Li J; Shi A
BMC Cancer; 2024 May; 24(1):596. PubMed ID: 38755542
[TBL] [Abstract][Full Text] [Related]
15. Lymph node dissection in esophageal carcinoma: Minimally invasive esophagectomy vs open surgery.
Ye B; Zhong CX; Yang Y; Fang WT; Mao T; Ji CY; Li ZG
World J Gastroenterol; 2016 May; 22(19):4750-6. PubMed ID: 27217706
[TBL] [Abstract][Full Text] [Related]
16. Impact of pathologically assessing extranodal extension in the thoracic field on the prognosis of esophageal squamous cell carcinoma.
Okada N; Daiko H; Kanamori J; Sato A; Horikiri Y; Sato T; Fujiwara H; Tomioka T; Fujita T; Kojima T; Fujii S
Surgery; 2019 Jun; 165(6):1203-1210. PubMed ID: 30850155
[TBL] [Abstract][Full Text] [Related]
17. Comparison of short- and long-term outcomes between 3-field and modern 2-field lymph node dissections for thoracic oesophageal squamous cell carcinoma: a propensity score matching analysis.
Fan N; Yang H; Zheng J; Chen D; Wang W; Tan Z; Huang Y; Lin P
Interact Cardiovasc Thorac Surg; 2019 Sep; 29(3):434-441. PubMed ID: 31135037
[TBL] [Abstract][Full Text] [Related]
18. Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study.
Cavallin F; Alfieri R; Scarpa M; Cagol M; Ruol A; Fassan M; Rugge M; Ancona E; Castoro C
BMC Surg; 2017 May; 17(1):49. PubMed ID: 28464907
[TBL] [Abstract][Full Text] [Related]
19. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma].
Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998
[TBL] [Abstract][Full Text] [Related]
20. Comparison of minimally invasive Ivor Lewis esophagectomy and left transthoracic esophagectomy in esophageal squamous cell carcinoma patients: a propensity score-matched analysis.
Wang Q; Wu Z; Zhan T; Fang S; Zhang S; Shen G; Wu M
BMC Cancer; 2019 May; 19(1):500. PubMed ID: 31132995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
